Literature DB >> 17593480

Salvage lymphadenectomy of the right recurrent nerve node with tracheal involvement after definitive chemoradiation therapy for esophageal squamous cell carcinoma: report of two cases.

Yuichiro Doki1, Takushi Yasuda, Hiroshi Miyata, Yoshiyuki Fujiwara, Shuji Takiguchi, Makoto Yamasaki, Yoichi Makari, Jin Matsuyama, Takeshi Masuoka, Morito Monden.   

Abstract

Thoracic esophageal cancers frequently metastasize to the right recurrent nerve nodes (RRNNs). In fact, huge RRNNs invading the trachea sometimes remain after definitive chemoradiation therapy (CRT), despite complete remission of the primary lesion. We performed salvage lymphadenectomy of a large RRNN combined with partial resection of the trachea in two patients. Using an anterior approach, we removed part of the sternum, clavicle, and the first and second costal cartilage; then, we removed the RRNNs with combined resection of the lateral quarter circumference of the trachea, the esophageal wall, and the recurrent nerve. Reconstruction was done with a musculocutaneous patch of major pectoral muscle to cover the tracheal defect. The only minor complication was venous thrombosis in one patient. Thus, combined removal of the RRNN and trachea was performed safely as a salvage operation after definitive CRT for esophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593480     DOI: 10.1007/s00595-006-3447-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Combined resection of the aorta for an esophageal carcinoma invading the aorta through a right transthoracic approach.

Authors:  T Kabuto; T Yasuda; H Furukawa; M Higashiyama; K Takami; H Yokouchi; K Kodama; H Takami; T Kobayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

2.  Statistical survey of tracheobronchoplasty in Japan.

Authors:  M Maeda; K Nakamoto; M Ohta; K Nakamura; S Nanjo; K Taniguchi; N Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  1989-03       Impact factor: 5.209

3.  Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.

Authors:  Nicolas Plaisant; Pierre Senesse; David Azria; Claire Lemanski; Marc Ychou; Francois Quenet; Bernard Saint-Aubert; Philippe Rouanet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.

Authors:  A Ohtsu; N Boku; K Muro; K Chin; M Muto; S Yoshida; M Satake; S Ishikura; T Ogino; Y Miyata; S Seki; K Kaneko; A Nakamura
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

6.  Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Authors:  Ines Gockel; Werner Kneist; Theodor Junginger
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

7.  Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.

Authors:  Yuichiro Doki; Ko Takachi; Osamu Ishikawa; Yo Sasaki; Isao Miyashiro; Hiroaki Ohigashi; Masahiko Yano; Ryu Ishihara; Yoshitane Tsukamoto; Kinji Nishiyama; Shingo Ishiguro; Shingi Imaoka
Journal:  Surgery       Date:  2005-05       Impact factor: 3.982

8.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Satoshi Ishikura; Keiji Nihei; Atsushi Ohtsu; Narikazu Boku; Shuichi Hironaka; Kiyomi Mera; Manabu Muto; Takashi Ogino; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

9.  Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis.

Authors:  Eero I T Sihvo; Markku E Luostarinen; Jarmo A Salo
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

10.  Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases.

Authors:  Yasumasa Nishimura; Kenji Nagata; Susumu Katano; Saeko Hirota; Katsumasa Nakamura; Fumi Higuchi; Toshinori Soejima; Heitetsu Sai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

View more
  5 in total

1.  Esophagectomy via left thoracotomy for esophageal cancer with situs inversus totalis: report of a case.

Authors:  Takahiro Mimae; Isao Nozaki; Akira Kurita; Shigemitsu Takashima
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

2.  Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy.

Authors:  Masanobu Nakajima; Yasushi Domeki; Hitoshi Satomura; Masakazu Takahashi; Akira Sugawara; Hiroto Muroi; Kinro Sasaki; Satoru Yamaguchi; Tatsuya Miyazaki; Hiroyuki Kuwano; Hiroyuki Kato
Journal:  Int Surg       Date:  2014 Jul-Aug

Review 3.  Secondary tracheal tumors: a systematic review.

Authors:  Maria Lucia Madariaga; Henning A Gaissert
Journal:  Ann Cardiothorac Surg       Date:  2018-03

4.  Salvage photodynamic therapy accompanied by extended lymphadenectomy for advanced esophageal carcinoma: A case report.

Authors:  Takahiro Nishida; Shinsuke Takeno; Koji Nakashima; Masato Kariya; Haruhiko Inatsu; Kazuo Kitamura; Atsushi Nanashima
Journal:  Int J Surg Case Rep       Date:  2017-05-26

5.  Long-term outcome after resection for recurrent oesophageal cancer.

Authors:  Fumihiko Kato; Satoko Monma; Kazuo Koyanagi; Jun Kanamori; Hiroyuki Daiko; Hiroyasu Igaki; Yuji Tachimori
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.